Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone

Trial Profile

Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Feb 2015

At a glance

  • Drugs Flurbiprofen (Primary) ; Remifentanil
  • Indications Abdominal pain; Pancreatitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Feb 2015 Status changed from recruiting to completed, according to ClincalTrials.gov record.
    • 06 Dec 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top